Evidence map›Paper›PMID 30798422›Full record

ArticleBreast cancer research and treatment2019

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.

Emily A Bossart, Nilgun Tasdemir, Matthew J Sikora, Amir Bahreini, Kevin M Levine, Jian Chen, Ahmed Basudan, Britta M Jacobsen, Timothy F Burns, Steffi Oesterreich

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Emily A BossartDepartment of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Nilgun TasdemirDepartment of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Matthew J SikoraDepartment of Pathology, University of Colorado Anschutz Medical Campus, Denver, CO, 80045, USA.
Amir BahreiniWomen's Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, 204 Craft Avenue, Pittsburgh, PA, 15213, USA.
Kevin M LevineWomen's Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, 204 Craft Avenue, Pittsburgh, PA, 15213, USA.
Jian ChenWomen's Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, 204 Craft Avenue, Pittsburgh, PA, 15213, USA.
Ahmed BasudanWomen's Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, 204 Craft Avenue, Pittsburgh, PA, 15213, USA.
Britta M JacobsenDepartment of Pathology, University of Colorado Anschutz Medical Campus, Denver, CO, 80045, USA.
Timothy F BurnsDepartment of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Steffi OesterreichDepartment of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA. oesterreichs@upmc.edu.ORCID http://orcid.org/0000-0002-8700-0251
University of Pittsburgh · USUniversity of Colorado Anschutz Medical Campus · USIsfahan University of Medical Sciences · IRKing Saud University · SAMagee-Womens Research Institute · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIEGFRIED, JILL M · 2001 to 2015
$34.6M
Elucidating the function of WNT4 in endocrine response and resistance in invasive lobular carcinomaK99CA193734 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIKORA, MATTHEW J · 2015 to 2016
$256k
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular CarcinomaF30CA203154 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, KEVIN MAX · 2017 to 2020
$170k
Targeting the EMT-like Phenotype in Invasive Lobular CarcinomaF31CA203055 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOSSART, EMILY ANN · 2016 to 2017
$84k
American Cancer Society 132939-RSG-18-185-01-TBGAmerican Lung Association LCD 257864Doris Duke Charitable Foundation 2015097National Cancer Institute 1F30CA203154-01National Cancer Institute 1F31CA203055-01National Cancer Institute K99 CA193734National Cancer Institute P30CA047904National Cancer Institute P50CA090440NCI NIH HHS F30 CA203154NCI NIH HHS F31 CA203055NCI NIH HHS K99 CA193734NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA090440Sidney Kimmel Foundation for Cancer Research SKF-15-099Susan G. Komen SAC160073U.S. Army BC110619U.S. Army BC160764V Foundation for Cancer Research Scholar Award
6 · The paper itself

Abstract

purposeInvasive lobular carcinoma (ILC) is a histological subtype of breast cancer that is predominantly estrogen receptor alpha (ER)-positive (+) and is thus treated with endocrine therapies. Herein, we sought to understand the molecular underpinnings of the 4-hydroxytamoxifen (4OHT) resistance in ILC by assessing the potential role of the epithelial-to-mesenchymal transition transcription factor (EMT-TF) SNAIL (SNAI1).

methodsUsing a series of breast cancer cell lines, we measured the basal, estrogen and 4OHT-induced expression of SNAIL and other EMT-TF family members by quantitative reverse transcription-polymerase chain reaction and immunoblotting. Chromatin immunoprecipitation experiments were performed to assess ER binding to the SNAIL promoter. Cell proliferation, cell cycle and apoptosis were assessed in 2D cultures. 3D growth was assessed in Matrigel and Collagen I cultures.

resultsEstrogen and 4OHT induced SNAIL expression, but not that of the other EMT-TF family members SLUG (SNAI2) and SMUC (SNAI3), with the 4OHT effect being specific to the lobular but not the ductal subtype. We observed estrogen and 4OHT-induced ER recruitment to the SNAI1 promoter and high endogenous basal levels of SNAIL and several EMT-TFs in ILC cell lines. While SNAIL knockdown had a minor impact on the 4OHT partial agonism in estrogen-depleted conditions, it led to a surprising increase in cell proliferation in full serum. In complementary experiments, inducible SNAI1 overexpression caused decreased proliferation, associated with a cell cycle arrest in G

conclusionThese data suggest a previously unrecognized role for SNAIL in ILC, substantiating a context-dependent behavior for this EMT-TF.

Indexed as

ApoptosisBreast NeoplasmsCarcinoma, LobularCell Cycle CheckpointsCell ProliferationDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionEstradiolEstrogen Receptor alphaFemaleGene Expression Regulation, NeoplasticHumansMCF-7 CellsNeoplasm InvasivenessSignal TransductionSnail Family Transcription FactorsafimoxifeneEstradiolEstrogen Receptor alphaSNAI1 protein, humanSnail Family Transcription FactorsTamoxifenBreast cancerEMTERLobularSNAILTamoxifen

Identifiers

PMID30798422
PMCPMC6625318
OpenAlexW2918105812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.